Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections

BC-3781 is a novel semisynthetic pleuromutilin antimicrobial agent developed as an intravenous and oral therapy for acute bacterial skin and skin structure infections (ABSSSI) and respiratory tract infections (RTI). BC-3781 and comparator agents were tested by the broth microdilution method against...

Full description

Saved in:
Bibliographic Details
Main Authors: Sader, Helio S., Biedenbach, Douglas J., Paukner, Susanne, Ivezic-Schoenfeld, Zrinka, Jones, Ronald N.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2012
Subjects:
Epidemiology and Surveillance
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294907/
https://ncbi.nlm.nih.gov/pubmed/22232289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05789-11
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items